ArticleBMJ open2024

Updated cost-effectiveness analysis of adebrelimab plus chemotherapy for extensive-stage small cell lung cancer in China.

Yunchun Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.